SEARCH Articles Figures Tables A Rationale for New Methods in Drug Discovery Abbreviated New Animal Drug Application ANADA) Abbreviated New Drug Application Abbreviated New Drug Applications ANDAs) Abbreviated new animal drug application Abbreviated new drug Abbreviated new drug application (ANDA Accelerated Access to New Drug Therapies Analogues as a Means of Discovering New Drugs Antidepressant drugs, new Approval of new drugs Approved new drug applications Clinical testing of new drugs phase Computer-assisted new drug Computer-assisted new drug application Drug and Cosmetic Industry, New York Drugs for a New Millennium Drugs, designing new Excipients in New Drugs Exploratory investigational new drug IND, Investigation New Drug IND, Investigation New Drug application Investigation new drug application Investigational Exemption for a New Drug Investigational New Drug Investigational New Drug Application INDA) Investigational New Drug Exemption Investigational New Drug IND), applications for Investigational New Drug application Investigational New Drugs Application Process Investigational New Drugs Application Process Phase Investigational new animal drug Investigational new drug application (IND Investigational new drug applications INDAs) Investigational new drug applications, FDA Investigational new drug regulations Investigational new drug studies Investigational new drug, IND Investigational new drug/clinical Investigational new drugs applications for Investigative new drug application Journey Toward New Drugs NDA (New Drug Application Natural Products as a Resource for Established and New Drugs Natural products leads for new drugs New Biological Targets for Drug Development New Concepts in the Drug Discovery Process New Drug Amendment New Drug Application , review New Drug Application submissions New Drug Applications (INDs) New Drug Applications (NDAs) New Drug Applications approval New Drug Development: Design, Methodology, and Analysis. By J. Rick Turner New Drug Policy New Drugs by Genetic Engineering New Leads from Old Drugs The SOSA Approach New Mexico Poison and Drug Information Center New Platinum Drugs New and Nonofficial Drugs New animal drug application New animal drug application NADA) New antimalarial drugs New drug apphcation New drug application New drug application contents New drug application filing New drug application process New drug application review process New drug applications , FDA New drug approval process New drug approvals New drug candidates New drug delivery systems New drug development New drug development process New drug entity New drug products New drug substance New drug therapy New drugs appearance New drugs review New uses for existing drugs New uses for old drugs Notice of Claimed Investigational Exemption for a New Drug Office of New Animal Drug Evaluation Office of New Drugs Old drugs, new uses Pharmaceutical Evaluation of New Drugs Plant Products as the Source of New Drugs Policy Statement for the Development of New Stereoisomeric Drugs Programmed Packaging A New Drug Delivery System and its Application to Gene Therapy Psychopharmacology and new drug development Q1A, stability testing of new drug substances and Regulatory Aspects of New Drug Development Regulatory approval of new drugs Stability Testing of New Drug Substances and Products Stability testing of new drug substances and The Emperor’s New Drugs The Search for New Natural Product Drugs The investigational new drug application The new drug application The role of clinical trials in new drug development Transforming New Molecular Entities into Drugs Using Investigational New Drugs What are drugs and why do we need new ones Why Drugs Fail - A Study on Side Effects in New Chemical Entities